Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07017023

Combined Blood Pressure Medication and Activity Scheduling for Low Mood

Cognitive Effects of Losartan-augmented Behavioural Activation in Anhedonia

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
76 (estimated)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study explores the effects of 7-day losartan (50mg) versus placebo with brief behavioural activation on emotional processing in young volunteers low in positive mood

Detailed description

Behavioural Activation (BA) is a first-line treatment for depression that aims to re-engage patients with rewarding activities, to improve mood. However, patients with low levels of positive mood respond less well to BA than others. Neuroscience has identified deficits in the processing of positive stimuli in this group of people, using cognitive-psychological computer tasks and brain imaging. Losartan, a licensed medication targeting the renin-angiotensin system, has recently been found to improve the processing of positive stimuli in healthy volunteers. Combining losartan with BA may improve treatment response in people with low positive mood, by improving positive information processing. This study will test this hypothesis. In a double-blind randomised trial, 76 participants with low positive mood will receive 7-day behavioural activation (BA) with daily losartan (50mg) or placebo. Before and after the intervention, they will complete computer tasks measuring processing of positive and negative information.

Conditions

Interventions

TypeNameDescription
DRUGLosartan with BA7-day losartan (Cozaar, 50mg; oral tablet) with 7-day BA
OTHERPlacebo with BA7-day placebo (oral; microcellulose in identical capsules) with 7-day BA

Timeline

Start date
2025-07-08
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-06-12
Last updated
2025-07-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07017023. Inclusion in this directory is not an endorsement.